Venezuela annuls two Bayer pharma patents
The government of Venezula has invalidated two patents registered in the country by Bayer for its antibiotic Avelox, local reports have confirmed.
Read MoreAuthor: Lynne Taylor
US consumer ads “led to higher drug prices”
A new study suggesting that US direct-to-consumer advertising (DTCA) for a top-selling drug had no effect on prescribing rates but led to a major rise in the drug’s price needs to be followed up, say the authors.
Read MoreUS pharma “now testing 97 HIV/AIDS drugs and vaccines”
Drugmakers in the USA are currently testing 97 new products for the prevention or treatment of HIV/AIDS and related conditions, including 23 vaccines and 54 antivirals, says the Pharmaceutical Research and Manufacturers of America (PhRMA).
Read MoreIreland to introduce reference pricing next year
Ireland will introduce reference pricing for medicines next year, government officials have confirmed.
Read MoreUS drugmakers’ fury over price probe demands
US drugmakers have reacted with fury to two separate calls by Members of Congress for official inquiries into allegations of industry “price gouging” in anticipation of health care reform.
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
